ArticleJournal of gastroenterology2011

High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b.

Hidenori Toyoda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.